Repro Med Systems Inc (REPR)

[blue_skies]

Andy Sealfon was on Mike King's radio show at the end of last week.Below is the link to the "podcast". REPR often uses Mike King's Princeton Research for PR.

http://www.rmsmedicalproducts.com/news/ceo-andy-sealfon-discusses-rms-company-updates-exciting-news/

A couple of things stuck out. Andy talked about REPR entering the neuromodulation market, which deals with how the body handles rejection. He described it as a huge market, a game changer similar to penicillin(paraphrasing Andy's words). Traditionally the neuromodulation drugs were administered via IV because of flow requirements. Previously, in home infusion devices, the needle size and flow restriction precluded their use in high flow applications. Simply put, you need the flow but do not want a large needle. No longer the case due to a new REPR patent pending needle design

During the podcast Andy referred to a new administration set, with a patent pending needle design that allowed a higher flow rate. This is huge!! This is a game changer because it will give REPR a unique competitive advantage for high flow applications. Additionally, the new needle design, enhances REPR value as a takeover candidate. It is better to own a technology and prevent the competition from having it.